• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Evaluation of human coronavirus OC43 and SARS-COV-2 in children with respiratory tract infection during the COVID-19 pandemic

tetano

Editor, Senior Moderator
J Med Virol


. 2021 Nov 16.
doi: 10.1002/jmv.27460. Online ahead of print.
Evaluation of human coronavirus OC43 and SARS-COV-2 in children with respiratory tract infection during the COVID-19 pandemic


Nasrin Keshavarz Valian[SUP] 1 [/SUP], Babak Pourakbari[SUP] 2 3 [/SUP], Kosar Asna Ashari[SUP] 3 [/SUP], Reihaneh Hosseinpour Sadeghi[SUP] 2 [/SUP], Shima Mahmoudi[SUP] 2 3 [/SUP]



Affiliations

Abstract

Background: The COVID-19 pandemic is an overwhelming crisis across the world. Human Coronavirus OC43 (HCoV-OC43) is a Betacoronavirus responsible mostly for mild respiratory symptoms. Since the presentations of HCoV-OC43 and SARS-COV-2 are believed to resemble a lot, the aim of this study was to evaluate the frequency and characteristics of HCoV-OC43 in the current pandemic and the rate of co-infection for the two viruses.
Methods: One hundred and seventeen patients referred to Children's Medical Center, Tehran, Iran with respiratory symptoms were included. Real-time reverse transcription-polymerase chain reaction (RT-PCR) methods were performed for detection of HCoV-OC43 and SARS-COV-2.
Result: Totally, 23 (20%) had a positive RT-PCR for HCoV-OC43 and 25 (21%) were positive for SARS-COV-2. Two patients (2%) had a positive PCR for both HCoV-OC43 and SARS-COV-2. The two groups showed significant differences in having contact with family members with suspected or confirmed COVID-19 (P value= 0.017), fever (P value= 0.02), edema (P value= 0.036), vomiting (P value <0.001), abdominal complaints (P value= 0.005) and myalgia (P value= 0.02). The median level of lymphocyte count in patients with HCoV-OC43 was significantly lower than patients with SARS-COV-2 infection (P value= 0.039).
Conclusion: The same frequency of SARS-COV-2 and HCoV-OC43 was found in children with respiratory symptoms during the COVID-19 pandemic. The rate of co-infection of SARS-COV-2 with HCoV-OC43 in our study was 0.08. Further research into the co-circulation of endemic coronaviruses, such as HCoV-OC43 and SARS-CoV2, in different regions is highly recommended. Attempts to determine the geographic distribution and recruit more flexible test panel designs are also highly recommended. This article is protected by copyright. All rights reserved.

Keywords: HCoV-OC43; Human Coronavirus; SARS-COV-2; children.
 
Back
Top Bottom